Form 4 for MET MetLife
Accepted 2023-08-11 00:00:00 ET · period of report 2023-08-09 · accession 0001099219-23-000211 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-11 | 2023-08-09 | MET | DEBEL MARLENE | EVP, CRO | S - Sale+OE | $63.18 | -9,391 | 77.6K | -11% | -$593.3K |
| D | 2023-08-11 | 2023-08-09 | MET | DEBEL MARLENE | EVP, CRO | M - OptEx | $45.15 | +10.9K | 87.0K | +14% | +$492.6K |
| D | 2023-08-11 | 2023-08-09 | MET | DEBEL MARLENE | EVP, CRO | M - OptEx | $0.00 | -10.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-09 | S | D | 9,391 | $63.18 | 77,638 | D | — | — | (F1) The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on August 9, 2023 and related tax obligations and fees. |
| 2 | Common | Common Stock | 2023-08-09 | M | A | 10,911 | $45.15 | 87,029 | D | — | — | |
| 3 | Derivative | Employee Stock Options (right to buy) | 2023-08-09 | M | D | 10,911 | $0.00 | 0 | D | $45.15 · — to 2024-02-24 | 10,911 Common Stock | (F2) The options became exercisable in three substantially equal installments on February 25, 2015, 2016 and 2017. |